Compendium of Cancer Genome Aberrations

Changes

HAEM5:Volunteer Assignments and Opportunities (view source)

Revision as of 15:06, 20 December 2023

1,672 bytes added ,  15:06, 20 December 2023
no edit summary
Line 888: Line 888:  
|
 
|
 
|-
 
|-
−
|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm
+
|[[HAEM5:Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 904: Line 904:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Blastic plasmacytoid dendritic cell neoplasm
+
|[[HAEM5:Blastic plasmacytoid dendritic cell neoplasm|Blastic plasmacytoid dendritic cell neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 920: Line 920:  
|Previously within myeloid section under JH/MS editors
 
|Previously within myeloid section under JH/MS editors
 
|-
 
|-
−
|Langerhans cell histiocytosis
+
|[[HAEM5:Langerhans cell histiocytosis|Langerhans cell histiocytosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 936: Line 936:  
|Date completed by author: 04/28/2022
 
|Date completed by author: 04/28/2022
 
|-
 
|-
−
|Langerhans cell sarcoma
+
|[[HAEM5:Langerhans cell sarcoma|Langerhans cell sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 952: Line 952:  
|Date completed by author: 04/28/2022
 
|Date completed by author: 04/28/2022
 
|-
 
|-
−
|Indeterminate dendritic cell tumour
+
|[[HAEM5:Indeterminate dendritic cell tumour|Indeterminate dendritic cell tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 968: Line 968:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Interdigitating dendritic cell sarcoma
+
|[[HAEM5:Interdigitating dendritic cell sarcoma|Interdigitating dendritic cell sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 984: Line 984:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Juvenile xanthogranuloma
+
|[[HAEM5:Juvenile xanthogranuloma|Juvenile xanthogranuloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,000: Line 1,000:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Erdheim-Chester disease
+
|[[HAEM5:Erdheim-Chester disease|Erdheim-Chester disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,016: Line 1,016:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Rosai-Dorfman Disease
+
|[[HAEM5:Rosai-Dorfman Disease|Rosai-Dorfman Disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,032: Line 1,032:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|ALK-positive histiocytosis
+
|[[HAEM5:ALK-positive histiocytosis|ALK-positive histiocytosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,048: Line 1,048:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Histiocytic sarcoma
+
|[[HAEM5:Histiocytic sarcoma|Histiocytic sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,083: Line 1,083:  
|
 
|
 
|-
 
|-
−
|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma
+
|[[HAEM5:Reactive B-cell rich lymphoid proliferations that can mimic lymphoma|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,099: Line 1,099:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|IgG4-related disease
+
|[[HAEM5:IgG4-related disease|IgG4-related disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,115: Line 1,115:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Unicentric Castleman disease
+
|[[HAEM5:Unicentric Castleman disease|Unicentric Castleman disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,131: Line 1,131:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|Idiopathic multicentric Castleman disease
+
|[[HAEM5:Idiopathic multicentric Castleman disease|Idiopathic multicentric Castleman disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,147: Line 1,147:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|KSHV/HHV8-associated multicentric Castleman disease
+
|[[HAEM5:KSHV/HHV8-associated multicentric Castleman disease|KSHV/HHV8-associated multicentric Castleman disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,163: Line 1,163:  
|Date completed by author: 01/24/2022
 
|Date completed by author: 01/24/2022
 
|-
 
|-
−
|B-lymphoblastic leukaemia/lymphoma
+
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,179: Line 1,179:  
|
 
|
 
|-
 
|-
−
|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy
+
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,195: Line 1,195:  
|
 
|
 
|-
 
|-
−
|B-lymphoblastic leukaemia/lymphoma with hypodiploidy
+
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy|B-lymphoblastic leukaemia/lymphoma with hypodiploidy]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,211: Line 1,211:  
|
 
|
 
|-
 
|-
−
|B-lymphoblastic leukaemia/lymphoma with iAMP21
+
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21|B-lymphoblastic leukaemia/lymphoma with iAMP21]]
 
|Disease
 
|Disease
 
|Holli authoring - Complete? Looks like needs more editing of tables
 
|Holli authoring - Complete? Looks like needs more editing of tables
Line 1,227: Line 1,227:  
|
 
|
 
|-
 
|-
−
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion
+
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,243: Line 1,243:  
|
 
|
 
|-
 
|-
−
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features
+
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,259: Line 1,259:  
|
 
|
 
|-
 
|-
−
|B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement
+
|[[HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement|B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,275: Line 1,275:  
|
 
|
 
|-
 
|-
−
|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion
+
|[[HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,291: Line 1,291:  
|
 
|
 
|-
 
|-
−
|B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features
+
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features|B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,307: Line 1,307:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
+
|[[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,323: Line 1,323:  
|
 
|
 
|-
 
|-
−
|B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion
+
|[[HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion|B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,339: Line 1,339:  
|
 
|
 
|-
 
|-
−
|B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion
+
|[[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion|B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,355: Line 1,355:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations
+
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,371: Line 1,371:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|B-lymphoblastic leukaemia/lymphoma, NOS
+
|[[HAEM5:B-lymphoblastic leukaemia/lymphoma, NOS|B-lymphoblastic leukaemia/lymphoma, NOS]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/13944"